Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
Clinical trial NCT06058299 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06058299
- Sponsor
- Global Alliance for TB Drug Development
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2024-12-27
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.